All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Formulary
Back
Contact us about this page
Chapter 2: Cardiovascular
Toggle Parent Pages
Print this page
Management of atrial fibrillation
Drugs that prolong the QT interval
Anticoagulation prescribing guidance
Management of suspected deep vein thrombosis (DVT) and pulmonary embolism (PE)
Secondary prevention of stroke / TIA in primary care
Management of angina
Chronic heart failure guidance
Management of hypertension
Management of blood lipids
2.1 Positive inotropic drugs
2.2 Diuretics
2.3 Anti-arrhythmic drugs
2.4 Beta-adrenoceptor blocking drugs
2.5 Hypertension and heart failure
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.7 Sympathomimetics
2.8 Anticoagulants and protamine
2.9 Antiplatelet drugs
2.10 Stable angina, acute coronary syndromes, and fibrinolysis
2.11 Antifibrinolytic drugs and haemostatics
2.12 Lipid regulating drugs
2.13 Local sclerosants
2.14 Miscellaneous cardiovascular preparations
Contact us about this page
2.5.4 Alpha-adrenoceptor blocking drugs
First Line
Second Line
Specialist
Hospital Only
Doxazosin
- Tablets 1mg, 2mg, 4mg (£0.78 = 2mg daily)
Indications
- Hypertension
- Benign prostatic hyperplasia
Notes
- Prolonged-release doxazosin is not recommended for use. Click here for more information
- Prescribers should not initiate prolonged-release doxazosin for any new patient
- Click the following link for a patient information leaflet to support deprescribing.
Phaeochromocytoma
Phenoxybenzamine hydrochloride
- Capsule 10mg
Phentolamine mesilate
- Injection 400 microgram in 1.7ml (unlicensed)
